Health

Vanguard summit: Mental health neglect threatens Nigeria’s stability – Sheikh

Vanguard summit: Mental health neglect threatens Nigeria’s stability – Sheikh

…Charges FG to enforce 2021 Act, expand services By Sola Ogundipe Nigeria’s neglect of mental health is threatening social stability, weakening public trust and deepening despair among young people struggling with insecurity, and diminishing their confidence in the future, Professor Taiwo Lateef Sheikh, a leading psychiatrist, has warned. Sheikh, a professor of psychiatry and psychopharmacology, […]
Visible Articles 5 10 15
World Vegan Day

World Vegan Day

October and November are the veg special months. October 1st kicks off the annual Vegetarian month. In between comes the World Food Day on October 16th – which was the topic of last week’s column.

IFC, HealthPlus seek reliable pharma services

IFC, HealthPlus seek reliable pharma services

In its bid to support in the drive for the delivery of quality pharmaceutical and personal care product, International Finance Company, IFC, a member of the World Bank Group, has signed a deal of agreement with HealthPlus Limited and CasaBella International Limited to provide a $5million loan facility to expand pharmaceutical and personal care services in Nigeria.

Ward off cancer with exercise — EXPERTS

Ward off cancer with exercise — EXPERTS

As the prevalence of cancers, particularly breast cancers continued to rise, experts have stressed the need for Nigerians to engage more in exercise saying that regular exercise helps to ward off diseases including cancer.

Nigerian doctors meet in Wales (2)

Nigerian doctors meet in Wales (2)

By Dr. Femi Ogunyemi • Continued from last Tuesday No mention was made of a fully comprehensive document “Nigeria MDGs Report 2013 ” available on the NPHCDA website. It includes the Government’s Millennium Acceleration Framework (MAF) for MDG 5. Dr. Obembe gave a very eloquent explanation of the NMAs primary objective of delivering Universal Health […]

WHO issues new guidelines on  treatment of MDR-TB

WHO issues new guidelines on treatment of MDR-TB

A new TB drug with a novel mechanism of action – delamanid – is now available for treatment of adults with multidrug-resistant tuberculosis (MDR-TB), a form of tuberculosis resistant to isoniazid and rifampicin, the main first-line TB drugs.